ABVX 株価推移チャート
ABVX 財務
ABIVAX Société Anonyme
$136.65
-0.81%
$-1.12
終値： Jul 17, 16:00:00 GMT-4
$136.5
-0.1%
$-0.15
アフターマーケット：Jul 17, 20:00:00 GMT-4
戻る
ABIVAX Société Anonyme (ABVX) 財務
主要データ
前終値
$137.77
始値
$136.07
当日レンジ
$134 - $138.36
52週レンジ
$9.86 - $148.83
取引高
1.4M
平均取引高
2.0M
配当利回り
--
1株当たり利益(TTM)
-5.25
時価総額
$11.8B
Abivax SAとは何ですか？
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 68 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
